Abstract
It is well established that strict glycemic control for the hospitalized stroke patient is associated with improved outcome compared with poor control. This is particularly true for the stroke patients because hyperglycemia can adversely affect ischemic damage. A blood sugar level of less than 110 mg/dL is recommended for critically ill patients and should be achieved by intravenous insulin administration in an intensive care unit setting. Many stroke patients are unable to swallow, and insulin requirement must be readjusted carefully to conform to the nutritional state of the patient. The transition from intravenous insulin to subcutaneous insulin or oral antihyperglycemic agents must be carefully monitored. Careful discharge planning of diabetic care for the stroke patient is necessary to prevent long-term sequelae of inadequate control.
Similar content being viewed by others
References and Recommended Reading
Van den Berghe G, Wouters P, Weekers F, et al.: Intensive insulin therapy in critically ill patients. N Engl J Med 2001, 345:1359–1367. Basic reference for the management of diabetes in critically ill patients.
Stagnaro-Green A, Barton MK, Linekin PL, et al.: Mortality in hospitalized patients with hypoglycemia and severe hyperglycemia. Mt Sinai J Med 1995, 62:422–426.
Capes SE, Hunt D, Malmberg K, Gerstein HC: Stress hyperglycemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet 2000, 355:773–778. Major study demonstrating adverse effects of hyperglycemia in acute cardiovascular disease.
Finney SJ, Zekveld C, Elia A, Evans TW: Glucose control and mortality in critically ill patients. JAMA 2003, 290:2041–2047.
Furnary AP, Wu Y, Bookin SO: Effect of hyperglycemia and continuous intravenous insulin infusions on outcomes of cardiac surgical procedures: the Portland Diabetic Project. Endocr Pract 2004, 10(Suppl 2):21–33.
Almbrand B, Johannesson M, Sjostrand B, et al.: Costeffectiveness of intense insulin treatment after acute myocardial infarction in patients with diabetes mellitus: results from the DIGAMI study. Eur Heart J 2000, 21:733–739.
Clement S, Braithwaite SS, Magee MF, et al.: Management of diabetes and hyperglycemia in hospitals. Diabetes Care 2004, 27:553–591.
Garber AJ, Moghissi ES, Bransome ED, et al.: American College of Endocrinology position statement on inpatient diabetes and metabolic control. Endocr Pract 2004, 10:77–82.
Dandona P, Aljada A, Bandyopadhyay A: The potential therapeutic role of insulin in acute myocardial infarction (DIGAMI study): effects on mortality at 1 year. J Am Coll Cardiol 1995, 26:57–65. Critical study demonstrating the benefit of glucose control in acute coronary syndromes.
Le Roith D: Molecular mechanisms by which metabolic control may improve outcomes. Endocr Pract 2004, 10(Suppl 2): 57–62.
Montori VM, Bistrian BR, McMahon MM: Hyperglycemia in acutely ill patients. JAMA 2002, 288:2167–2169.
Hirsch IB, Braithwaite SS, Verderese CA: Practical Management of Inpatient Hyperglycemia. Sano.-Aventis Monograph 06039. Lakeville, CT: Hilliard Publishing; 2005:1–41.
Trence DL, Kelly JL, Hirsch IB: the rationale and management of hyperglycemia for in-patients with cardiovascular disease: time for a change. J Clin Endocrinol Metab 2003, 88:2430–2437.
Braithwaite SS, Buie MM, Thompson CL, et al.: Hospital hypoglycemia: not only treatment but also prevention. Endocr Pract 2004, 10(Suppl 2): 89–99.
American Diabetes Association: Standards of medical care in diabetes. Diabetes Care 2005, 28:S4-S36.
Schloerb PR: Glucose in parenteral nutrition: a survey of US medical centers. J Parenter Enteral Nutr 2004, 28:447–452.
Jeejeebhoy KN: Permissive underfeeding of the critically ill patient. Nutr Clin Pract 2004, 19:477–480.
Campbell KB, Braithwaite SS: Hospital management of hyperglycemia. Clin Diabetes 2004, 22:81–88.
Bode BW, Braithwaite SS, Steed RD, Davidson PC: Intravenous insulin infusion therapy: indications, methods, and transition to subcutaneous insulin therapy. Endocr Pract 2004, 10:71–80.
Braithwaite SS: Case Study. Five steps to freedom: dose titration for type 2 diabetes using basal-prandial-correction insulin therapy. Clin Diabetes 2005, 23:39–43. This article details the management of diabetes treatment in critical patients.
Hirsch IB: Insulin analogues. N Engl J Med 2005, 352:174–183. New developments in the treatment of diabetes.
DAFNE Study Group: Training in flexible, intensive insulin management to enable dietary freedom in people with type 1 diabetes: dose adjustment for normal eating (DAFNE) randomized controlled trial. BMJ 2002, 325:746. Intensive management of diabetic patients.
DeWitt DE, Hirsch IB: Outpatient insulin therapy in type 1 and type 2 diabetes mellitus: scientific review. JAMA 2003, 289:2254–2264. Key review of the outpatient management of diabetes, including post hospitalization.
Hawkings JB, Morales CM, Shipp JC: Insulin requirements in 242 patients with type II diabetes mellitus. Endocr Pract 1995, 1:385–389.
Warshaw HS, Bolderman KM: Advanced carbohydrate counting. In Practical Carbohydrate Counting: a How-to-Teach Guide for Health Professionals. Alexandria: American Diabetes Association; 2001:26–28.
Shorr RI, Ray WA, Daugherty JR, Griffin MR: Incidence and risk factors for serious hypoglycemia in older persons using insulin or sulfonylureas. Arch Intern Med 1997, 157:1681–1686.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Burroughs, V., Weinberger, J. Diabetes and Stroke: Part two—Treating diabetes and stress hyperglycemia in hospitalized stroke patients. Curr Cardiol Rep 8, 29–32 (2006). https://doi.org/10.1007/s11886-006-0007-0
Issue Date:
DOI: https://doi.org/10.1007/s11886-006-0007-0